FULCRUM THERAPEUTICS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/355fc4a5-fd2e-4d81-b547-ea8e7cb25e22/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-065197 |
| FY 2024 | $80.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-026068 |
| FY 2023 | $2.8M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-021074 |
| FY 2022 | $6.3M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006841 |
| FY 2021 | $19.2M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002727 |
| FY 2020 | $8.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-010715 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
FULCRUM THERAPEUTICS, INC. — all facts · Net Income · Operating Income